Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.15M Sell
14,691
-3,122
-18% -$566K 0.52% 37
2026
Q1
$2.62M Buy
17,813
+3,702
+26% +$602K 0.67% 34
2025
Q4
$2.75M Buy
14,111
+5,505
+64% +$1.31M 0.71% 32
2025
Q3
$2.42M Sell
8,606
-1,018
-11% -$259K 0.72% 31
2025
Q2
$2.1M Buy
9,624
+7,897
+457% +$1.28M 0.64% 32
2025
Q1
$241K Buy
1,727
+289
+20% +$47.1K 0.08% 91
2024
Q4
$240K Buy
1,438
+58
+4% +$10.3K 0.08% 92
2024
Q3
$235K Buy
+1,380
New +$200K 0.08% 98

Other funds holding ORCL

Hilltop Partners's ORCL Position: Q2 2026 in Review

Hilltop Partners reduced its Oracle (ORCL) stake by 18% in Q2 2026, selling an estimated $566K and leaving 14,691 shares worth $2.15M. The position accounts for 0.52% of the portfolio, ranked #37.

Hilltop Partners first reported a position in ORCL in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.75M in Q4 2025. 3,519 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Hilltop Partners held 14,691 shares of Oracle worth $2.15M as of Q2 2026.
  • Hilltop Partners sold 3,122 Oracle shares in Q2 2026, an estimated $566K.
  • Oracle made up 0.52% of Hilltop Partners's portfolio in Q2 2026, its #37 holding.
  • Hilltop Partners first reported a position in Oracle in Q3 2024 and has held it in 8 quarters since.
  • Hilltop Partners's Oracle position peaked at $2.75M in Q4 2025.
  • 3,519 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Hilltop Partners's 13F filing for Q2 2026, filed 5 Aug 2026.